These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3905005)

  • 1. Epoprostenol (PGI2) reduces the incidence of post-reperfusion ventricular fibrillation in the dog.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Serradimigni A
    Cardiologia; 1985 Feb; 30(2):91-7. PubMed ID: 3905005
    [No Abstract]   [Full Text] [Related]  

  • 2. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
    J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB; Mardin M
    Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR; Verrier RL; Lown B
    Eur J Pharmacol; 1982 May; 80(1):83-91. PubMed ID: 7047179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reperfusion ventricular fibrillation in the dog].
    Málek I; Kolc J; Málek P
    Cas Lek Cesk; 1982 Jul; 121(27):857-61. PubMed ID: 6126273
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of myocardial protection with prostacyclin during cardiac arrest.
    Vincent JL; Domb M; Goldstein J; Lignian H; Van Belle J
    Prostaglandins Leukot Med; 1986 Sep; 24(1):87-92. PubMed ID: 3532136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death.
    Hammon JW; Oates JA
    Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular recording from the in situ working dog heart in physiological conditions and during acute ischemia and fibrillation.
    Czarnecka M; Lewartowski B; Prokopczuk A
    Acta Physiol Pol; 1973; 24(2):331-7. PubMed ID: 4711432
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventricular fibrillation after acute coronary artery occlusion. An experimental study.
    Pifarré R; Yokoyama T; Ilano AC; Hufnagel CA
    J Thorac Cardiovasc Surg; 1967 Mar; 53(3):335-40. PubMed ID: 6019145
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early electrocardiographic changes produced by multiple coronary ligations in the dog].
    Teodorin S; Georgescu M; Dobreanu-Enescu V
    Stud Cercet Med Interna; 1969; 10(1):67-87. PubMed ID: 4186496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril].
    Zhang M; Pan JY; Zhu XN; Zhan CY
    Sheng Li Xue Bao; 1995 Dec; 47(6):559-64. PubMed ID: 8762446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the genesis of ventricular fibrillation in the course of a temporary occlusion of the coronary artery. II.
    Wojtowicz M; Dybicki J; Zawistowski S; Wrzolek S; Bartoszewicz T
    Pol Med J; 1967; 6(2):479-81. PubMed ID: 6030655
    [No Abstract]   [Full Text] [Related]  

  • 14. Cesium in the prevention of cardiac arrhythmias induced by coronary ligation.
    Prasad K; Simani AS; Dolan AM; Sterns LP; Callaghan JC
    Surg Forum; 1970; 21():166-7. PubMed ID: 5514720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ventricular fibrillation threshold changes following acute and chronic epicardiectomy in dogs].
    Tóth I; Török B
    Thoraxchir Vask Chir; 1968 Jun; 16(3):220-6. PubMed ID: 5250147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of NO-synthetase inhibitor L-NAME on occlusive and reperfusion arrhythmias in cats].
    Kukushkina OI; Fedotkina LK; Balashov VP; Balykova LA; Sosunov AA
    Biull Eksp Biol Med; 1999 May; 127(5):509-11. PubMed ID: 10399567
    [No Abstract]   [Full Text] [Related]  

  • 17. Synchronized counterpulsation in the management of ventricular fibrillation following coronary artery ligation.
    Fleming WH; Schultz J; Malm JR
    J Thorac Cardiovasc Surg; 1968 Aug; 56(2):253-7. PubMed ID: 5701815
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study of the use of magnesium and of ajmaline in ventricular bathmotropic disorders secondary to acute coronary occlusion].
    Critelli G; Cernigliaro C; Rizzo S; Santucci A; Marigliano V; Giuliano G
    Atti Soc Ital Cardiol; 1969 Jan; 2():270-81. PubMed ID: 5406542
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Observations on its mode of action.
    Fearon RE
    Am J Cardiol; 1967 Aug; 20(2):222-8. PubMed ID: 4951347
    [No Abstract]   [Full Text] [Related]  

  • 20. [The protective effect of DOPA and dopamine in experimental coronary insufficiency].
    Popova NK; Shmerling MD
    Biull Eksp Biol Med; 1967 Aug; 64(8):56-9. PubMed ID: 5622545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.